ABATTIS BIOCEUTICA (ATTBF)

0.28
OTC Markets
Prev Close 0.28
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.05 / 0.74
Exchange OTC Markets
Shares Outstanding 178.46B
Market Cap 49.97M
Div & Yield N.A. (N.A)

Latest News

Abattis Partners With Vancouver-Based Craft Brewer To Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer

Abattis Partners With Vancouver-Based Craft Brewer To Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer

Northern Vine Laboratories Selected to Provide Hemp Extract, and Research & Development and Analytical Testing Services to Develop CBD Beer

Abattis Confirms Breakthrough Extraction Technology Capabilities

Abattis Confirms Breakthrough Extraction Technology Capabilities

Abattis looks to become a leader in extraction with proprietary extraction technology

Abattis Announces Completion Of Investment By Emerald Health Therapeutics In Northern Vine

Abattis Announces Completion Of Investment By Emerald Health Therapeutics In Northern Vine

Emerald and Abattis positioned to grow analytical testing and import opportunities facilitated by Northern Vines' recently renewed Licensed Dealer Laboratory

GWPH Momentum Passed Around to Other Pot Stocks

GWPH Momentum Passed Around to Other Pot Stocks

GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.

Cannabis Companies Hunt for Financing, Growth

Cannabis Companies Hunt for Financing, Growth

Companies in the cannabis business have an appetite for capital to fuel what has emerged as one of the largest growth sectors, and more investors are taking the risk.

Baby Boomers Spend Billions To Stay Young

Baby Boomers Spend Billions To Stay Young

Abattis Bioceuticals Signs $25 Million Deal With Dutchess Fund

Canaccord Fumes Over Pot Deal

Canaccord Fumes Over Pot Deal

The Toronto-based wealth management and securities company helped aspiring pot grower Enertopia raise over a million dollars but, upon being informed by TheStreet that it had been credited in a regulatory filing, Canaccord wasn't feeling the vibes.